PMC:7554011 / 24185-24662 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7554011","sourcedb":"PMC","sourceid":"7554011","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7554011","text":"In the in vivo studies of Singulair® granules (4 mg) administered to infant patients, medicine administration was conducted by mixing the formulation with different vehicles: formula (5 mL) to infants 1 to 3 months, and applesauce (15 g) to infants from 3 to 24 months (two subgroups: 3 to 6 and 6 to 24 months). The prandial state of the patients in these studies was not disclosed and potential vehicle-induced differences on drug behaviour were not considered (16,17,19,23).","tracks":[{"project":"2_test","denotations":[{"id":"33051713-16707408-26807","span":{"begin":464,"end":466},"obj":"16707408"},{"id":"33051713-18296556-26808","span":{"begin":467,"end":469},"obj":"18296556"},{"id":"33051713-15102869-26809","span":{"begin":470,"end":472},"obj":"15102869"},{"id":"33051713-25670209-26810","span":{"begin":473,"end":475},"obj":"25670209"}],"attributes":[{"subj":"33051713-16707408-26807","pred":"source","obj":"2_test"},{"subj":"33051713-18296556-26808","pred":"source","obj":"2_test"},{"subj":"33051713-15102869-26809","pred":"source","obj":"2_test"},{"subj":"33051713-25670209-26810","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#eb93ec","default":true}]}]}}